参考文献：
［1］ROULOT D.Liver involvement in Turner syndrome［J］.Liver Int,2013,33:24-30.
［2］SYLVEN L,HAGENFELDT K,BRONDUM-NIELSEN K,et al. Middle-aged women with Turner’s syndrome. Medical status,hormonal treatment and social life.Acta Endocrinol,1991,125:359-365.
［3］LARIZZA D,LOCATELLI M,VITALI L,et al.Serum liver enzymes in Turner syndrome.Eur J Pediatr,2000,159:143-148.
［4］SALERNO M,DI MAIO S,GASPARINI N,et al.Liver abnor-malities in Turner syndrome.Eur J Pediatr,1999,158,618-623.
［5］ELSHEIKH M,HODGSON H J,WASS J A,et al.Hormone replacement therapy may improve hepatic function in women with Turner’s syndrome.Clin Endocrinol,2001,55:227-311.
［6］El-MANSOURY M,BERNTORP K,BRYMAN I,et al.Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin Endocrinol,2008,68:485-490.
［7］李光玲，阳洪波.特纳综合征患者肝功能异常的高发生率及其影响因素［J］.基础医学与临床，2016，36（5）：699-701.
［8］孙焱，刘靖芳，汤旭磊，等.15 例Turner 综合征患者临床特征和染色体核型分析［J］.临床荟萃，2017，32（8）：681-685.
［9］MAZZANTI L,CACCIARI E.Congenital heart disease in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome（ISGTS）［J］.J Pediatr,1998,133:688-692.
［10］PRANDSTRALLER D,MAZZANTI L,PICCHIO FM,et al.Turner’s syndrome:cardiologic profile according to the different chromosomal patterns and long-term clinical follow-Up of 136 nonpreselected patients［J］.Pediatr Cardiol,1999,20:108-112.
［11］OSTERG J E,DONALD A E,HALCOX J P,et al.Vasculopathy in Turner syndrome:arterial dilatation and intimal thicken-ing without endothelial dysfunction［J］. J Clin Endocrinol Metab,2005,90:5161-5166.
［12］HJERRILD B E,MORTENSEN K H,SORENSEN K E,et al.Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure:a CMR study. J Cardjovasc Magn reson,2010,12:36.
［13］MORTENSEN K H,ANDERSEN N H,HJERRILD B E,et al.Carotid intimamedia thickness is increased in Turner syndrome:multifactorial pathogenesis depending on age,blood pres-sure,cholesterol and oestrogen treatment. Clin Endocrinol［J］,2012,77:844-851.(https://www.daowen.com)
［14］NOE J A,PITTMAN H C,BURTON E M.Congenital absence of the portal vein in a child with Turner syndrome［J］. Pediatr Radiol,2006,36:566-568.
［15］MOROTTI R A,KILLACKEY M,SHNEIDER B L,et al.Hepatocellu-lar carcinoma and congenital absence of the portal vein in a child receiving growth hormone therapy for turner syn-drome［J］. Semin Liver Dis,2007,27:427-431.
［16］ROULOT D.Liver involvement in Turner syndrome［J］.Liver Int,2013,33:24-30.
［17］JOBE S,DONOHOUE P,DI PAOLA J.Deep venous thrombosis and turner syndrome［J］.J Pediatr Hematol Oncol,2004,26:272.
［18］KOPACEK Z C,KELLER B J,ELNECAVE R H.Portal vein thrombo-sis and highfactor Ⅷ in Turner syndrome［J］. Horm Res,2006,66:89-93.
［19］GOMEZ ANTUNEZ M,CUENCA CARVAJAL C,ORTIZ VEGA M,et al. Association of primary biliary cirrhosis,Turner’s syndrome and chronic myeloid leukemia［J］.Gastroenterol Hepatol,1997,20:44-45.
［20］SOKOL L,STUEBEN E T,JAIKISHEN J P,LAMARCHE M B.Turner syndrome associated with acquired von Willebrand disease,primary biliary cirrhosis, and inflammatory bowel disease［J］. Am J Hematol,2002,70:257-259.
［21］MILKIEWICZ P,HEATHCOTE J.Primary biliary cirrhosis in a patient with Turner syndrome［J］.Can J Gastroenterol,2005,19:631-633.
［22］FUKUZUMI S,MORIYA Y,MAKUUCHI M,TERUI S.Serious chemical sclerosing cholangitis associated with hepatic arterial 5FU and MMC chemotherapy［J］.Eur J Surg Oncol,1990,16:251-255.
［23］ELSHEIKH M,DUNGER DB,CONWAY GS,et al.Turner’s syndrome in adulthood［J］.Endocr Rev,2002,23:120-140.
［24］闫洁，桑艳梅，倪桂臣，等.重组人生长激素对38 例特纳综合征的疗效观察［J］.中华实用儿科临床杂志，2012（8）：631-633.
（王洪燕 陈明胜 吴文杰 江晓燕）